Cargando…

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019

Between January 2018 and May 2019, 349 cases of Candida auris were reported in the European Union/European Economic Area*, 257 (73.6%) colonisations, 84 (24.1%) bloodstream infections, seven (2.0%) other infections and one case of unknown infection/colonisation status (0.3%). Most cases (97.1%, n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plachouras, Diamantis, Lötsch, Felix, Kohlenberg, Anke, Monnet, Dominique L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118346/ https://www.ncbi.nlm.nih.gov/pubmed/32234118 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.12.2000240

Ejemplares similares

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
por: Kinross, Pete, et al.
Publicado: (2020)

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
por: Brolund, Alma, et al.
Publicado: (2019)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
por: Peñalva, Germán, et al.
Publicado: (2019)

Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
por: Lötsch, Felix, et al.
Publicado: (2020)

Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area
por: Mårdh, Otilia, et al.
Publicado: (2023)

Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022
por: Linkevicius, Marius, et al.
Publicado: (2023)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
por: van Sighem, Ard, et al.
Publicado: (2017)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Health crisis in Venezuela: Status of communicable diseases and implications for the European Union and European Economic Area, May 2019
por: Espinosa, Laura, et al.
Publicado: (2019)

Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
por: Johnson, Helen C, et al.
Publicado: (2020)

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019
por: Stathi, Angeliki, et al.
Publicado: (2019)

2166. Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) Hospitals, 2018
por: Jeldes, Felipe Garcia, et al.
Publicado: (2018)

Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
por: Suetens, Carl, et al.
Publicado: (2021)

Cross-border spread of bla(NDM-1)- and bla(OXA-48)-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
por: Ludden, Catherine, et al.
Publicado: (2020)

Incursions of Candida auris into Australia, 2018
por: Lane, Courtney R., et al.
Publicado: (2020)

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
por: Alm, Erik, et al.
Publicado: (2020)

Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018
por: Domingo, Cristina, et al.
Publicado: (2018)

Gender and organizational culture in the European Union: situation and prospects
por: Alonso Gallo, Nuria, et al.
Publicado: (2023)

The architecture of the European Union’s pandemic preparedness and response policy framework
por: Eerens, Dimitri, et al.
Publicado: (2022)

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
por: Spiteri, Gianfranco, et al.
Publicado: (2020)

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
por: Walter, Jan, et al.
Publicado: (2018)

First hospital outbreak of the globally emerging Candida auris in a European hospital
por: Schelenz, Silke, et al.
Publicado: (2016)

An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018–21 January 2019: early findings
Publicado: (2019)

Beware of the commercialization of human cells and tissues: situation in the European Union
por: Pirnay, Jean-Paul, et al.
Publicado: (2012)

Art of Disaster Preparedness in European Union: a Survey on the Health Systems
por: Djalali, Ahmadreza, et al.
Publicado: (2014)

Securing circulation pharmaceutically: Antiviral stockpiling and pandemic preparedness in the European Union
por: Elbe, Stefan, et al.
Publicado: (2014)

Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019
por: Crea, Francesca, et al.
Publicado: (2019)

HIV among women in the WHO European Region – epidemiological trends and predictors of late diagnosis, 2009-2018
por: Mårdh, Otilia, et al.
Publicado: (2019)

Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018
por: Young, Johanna J, et al.
Publicado: (2021)

In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022
por: Codda, Giulia, et al.
Publicado: (2023)

The 2018 European Union report on pesticide residues in food
por: Medina‐Pastor, Paula, et al.
Publicado: (2020)

The European Union One Health 2018 Zoonoses Report
Publicado: (2019)

Potential Fifth Clade of Candida auris, Iran, 2018
por: Chow, Nancy A., et al.
Publicado: (2019)

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ojt73cru904hgk667uuhv93t5u